Shareholders of James Hardie Industries plc. Should Contact The Gross Law Firm Before December 23, 2025 to Discuss Your Rights – JHX

(NYSE:JHX), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased shares of JHX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required […]

Lost Money on Stride, Inc.(LRN)? Join Class Action Suit Seeking Recovery – Contact The Gross Law Firm

(NYSE:LRN), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Stride, Inc. (NYSE: LRN). Shareholders who purchased shares of LRN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

(NASDAQ:DXCM), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Shareholders of James Hardie Industries plc. Should Contact The Gross Law Firm Before December 23, 2025 to Discuss Your Rights – JHX

Shareholders of James Hardie Industries plc. Should Contact The Gross Law Firm Before December 23, 2025 to Discuss Your Rights – JHX GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased shares

Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action – Contact The Gross Law Firm to Learn More

Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action – Contact The Gross Law Firm to Learn More GlobeNewswire December 08, 2025 NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during

December 15, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BAX

(NYSE:BAX), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Baxter International, Inc. (NYSE: BAX). Shareholders who purchased shares of BAX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

Investors who lost money on Skye Bioscience, Inc.(SKYE) should contact The Gross Law Firm about pending Class Action – SKYE

(NasdaqGM:SKYE), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 12, 2026 in Firefly Aerospace Inc. Lawsuit – FLY

(NasdaqGM:FLY), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Firefly Aerospace Inc. (NASDAQ: FLY). Shareholders who purchased shares of FLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX)

(NASDAQ:MLTX), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of MoonLake Immunotherapeutics (NASDAQ: MLTX). Shareholders who purchased shares of MLTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

Scroll to Top